instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the outcome of reaction 'Generalised tonic-clonic seizure'? | Adjunctive use of the ketogenic diet in a young adult with UBE2A deficiency syndrome and super-refractory status epilepticus.
The ketogenic diet (KD) may have a role in treating super-refractory status epilepticus (SRSE). Predominantly used in paediatric epilepsy, there are few reports of its use in adults. We describe... | Recovered | ReactionOutcome | CC BY-NC-ND | 34095805 | 20,264,433 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ductus arteriosus stenosis foetal'. | Foetal ductus arteriosus constriction unrelated to non-steroidal anti-Inflammatory drugs: a case report and literature review.
Foetal ductus arteriosus (DA) constriction can be found in complex foetal heart malformations, but rarely as an isolated defect. Although many cases of DA constriction are usually related to No... | FLUOXETINE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34096417 | 16,369,075 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Foetal exposure during pregnancy'. | Foetal ductus arteriosus constriction unrelated to non-steroidal anti-Inflammatory drugs: a case report and literature review.
Foetal ductus arteriosus (DA) constriction can be found in complex foetal heart malformations, but rarely as an isolated defect. Although many cases of DA constriction are usually related to No... | FLUOXETINE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34096417 | 16,369,075 | 2021-12 |
What was the administration route of drug 'FLUOXETINE HYDROCHLORIDE'? | Foetal ductus arteriosus constriction unrelated to non-steroidal anti-Inflammatory drugs: a case report and literature review.
Foetal ductus arteriosus (DA) constriction can be found in complex foetal heart malformations, but rarely as an isolated defect. Although many cases of DA constriction are usually related to No... | Transplacental | DrugAdministrationRoute | CC BY | 34096417 | 16,369,075 | 2021-12 |
What was the outcome of reaction 'Ductus arteriosus stenosis foetal'? | Foetal ductus arteriosus constriction unrelated to non-steroidal anti-Inflammatory drugs: a case report and literature review.
Foetal ductus arteriosus (DA) constriction can be found in complex foetal heart malformations, but rarely as an isolated defect. Although many cases of DA constriction are usually related to No... | Recovered | ReactionOutcome | CC BY | 34096417 | 16,369,075 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'No adverse event'. | Medication Use in the Management of Comorbidities Among Individuals With Autism Spectrum Disorder From a Large Nationwide Insurance Database.
Although there is no pharmacological treatment for autism spectrum disorder (ASD) itself, behavioral and pharmacological therapies have been used to address its symptoms and comm... | ARIPIPRAZOLE | DrugsGivenReaction | CC BY | 34097007 | 19,917,940 | 2021-09-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatitis E'. | Severe Hepatitis E virus infection in a patient with rheumatoid arthritis treated with baricitinib.
A patient with rheumatoid arthritis (RA) was presented, who developed an infection with the hepatitis E virus (HEV) under treatment with the Janus kinase (JAK) 1 and 2 inhibitor baricitinib. In the 3‑month routine check-... | ATORVASTATIN, FEBUXOSTAT, METHOTREXATE | DrugsGivenReaction | CC BY | 34097102 | 20,631,649 | 2021-12 |
What was the dosage of drug 'METHOTREXATE SODIUM'? | Severe Hepatitis E virus infection in a patient with rheumatoid arthritis treated with baricitinib.
A patient with rheumatoid arthritis (RA) was presented, who developed an infection with the hepatitis E virus (HEV) under treatment with the Janus kinase (JAK) 1 and 2 inhibitor baricitinib. In the 3‑month routine check-... | DOSES BETWEEN 10 AND 15 MG/WEEK | DrugDosageText | CC BY | 34097102 | 20,678,507 | 2021-12 |
What was the outcome of reaction 'Hepatitis E'? | Severe Hepatitis E virus infection in a patient with rheumatoid arthritis treated with baricitinib.
A patient with rheumatoid arthritis (RA) was presented, who developed an infection with the hepatitis E virus (HEV) under treatment with the Janus kinase (JAK) 1 and 2 inhibitor baricitinib. In the 3‑month routine check-... | Recovered | ReactionOutcome | CC BY | 34097102 | 20,631,649 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neuropathy peripheral'. | Transplant-associated penile Kaposi sarcoma managed with single agent paclitaxel chemotherapy: a case report.
BACKGROUND
Kaposi's sarcoma is an uncommon complication in renal transplant patients, and typically presents with cutaneous lesions on the lower extremities. Penile involvement has been reported only rarely. Ma... | APIXABAN, BASILIXIMAB, EVEROLIMUS, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL, PACLITAXEL, PREDNISONE, TACROLIMUS | DrugsGivenReaction | CC BY | 34098936 | 19,552,202 | 2021-06-07 |
What was the dosage of drug 'BASILIXIMAB'? | Transplant-associated penile Kaposi sarcoma managed with single agent paclitaxel chemotherapy: a case report.
BACKGROUND
Kaposi's sarcoma is an uncommon complication in renal transplant patients, and typically presents with cutaneous lesions on the lower extremities. Penile involvement has been reported only rarely. Ma... | INDUCTION THERAPY | DrugDosageText | CC BY | 34098936 | 19,552,202 | 2021-06-07 |
What was the dosage of drug 'EVEROLIMUS'? | Transplant-associated penile Kaposi sarcoma managed with single agent paclitaxel chemotherapy: a case report.
BACKGROUND
Kaposi's sarcoma is an uncommon complication in renal transplant patients, and typically presents with cutaneous lesions on the lower extremities. Penile involvement has been reported only rarely. Ma... | MAINTENANCE THERAPY | DrugDosageText | CC BY | 34098936 | 19,552,202 | 2021-06-07 |
What was the dosage of drug 'METHYLPREDNISOLONE'? | Transplant-associated penile Kaposi sarcoma managed with single agent paclitaxel chemotherapy: a case report.
BACKGROUND
Kaposi's sarcoma is an uncommon complication in renal transplant patients, and typically presents with cutaneous lesions on the lower extremities. Penile involvement has been reported only rarely. Ma... | INDUCTION THERAPY | DrugDosageText | CC BY | 34098936 | 19,552,202 | 2021-06-07 |
What was the dosage of drug 'MYCOPHENOLATE MOFETIL'? | Transplant-associated penile Kaposi sarcoma managed with single agent paclitaxel chemotherapy: a case report.
BACKGROUND
Kaposi's sarcoma is an uncommon complication in renal transplant patients, and typically presents with cutaneous lesions on the lower extremities. Penile involvement has been reported only rarely. Ma... | MAINTENANCE THERAPY | DrugDosageText | CC BY | 34098936 | 19,552,202 | 2021-06-07 |
What was the dosage of drug 'PACLITAXEL'? | Transplant-associated penile Kaposi sarcoma managed with single agent paclitaxel chemotherapy: a case report.
BACKGROUND
Kaposi's sarcoma is an uncommon complication in renal transplant patients, and typically presents with cutaneous lesions on the lower extremities. Penile involvement has been reported only rarely. Ma... | UNK, QW | DrugDosageText | CC BY | 34098936 | 19,506,963 | 2021-06-07 |
What was the dosage of drug 'TACROLIMUS'? | Transplant-associated penile Kaposi sarcoma managed with single agent paclitaxel chemotherapy: a case report.
BACKGROUND
Kaposi's sarcoma is an uncommon complication in renal transplant patients, and typically presents with cutaneous lesions on the lower extremities. Penile involvement has been reported only rarely. Ma... | MAINTENANCE THERAPY | DrugDosageText | CC BY | 34098936 | 19,552,202 | 2021-06-07 |
What was the outcome of reaction 'Kaposi^s sarcoma'? | Transplant-associated penile Kaposi sarcoma managed with single agent paclitaxel chemotherapy: a case report.
BACKGROUND
Kaposi's sarcoma is an uncommon complication in renal transplant patients, and typically presents with cutaneous lesions on the lower extremities. Penile involvement has been reported only rarely. Ma... | Recovered | ReactionOutcome | CC BY | 34098936 | 19,464,738 | 2021-06-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hyponatraemia'. | From hypotonic maintenance fluid to severe hyponatremia: a case report.
BACKGROUND
The principles for maintenance intravenous fluid prescription in children were developed in the 1950s. These guidelines based on the use of hypotonic solutions have been challenged regularly for they seem to be associated with an increas... | BETAMETHASONE, CALCIUM, DEXTROSE, POTASSIUM, SODIUM CHLORIDE | DrugsGivenReaction | CC BY | 34099019 | 19,499,359 | 2021-06-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hyponatraemic encephalopathy'. | From hypotonic maintenance fluid to severe hyponatremia: a case report.
BACKGROUND
The principles for maintenance intravenous fluid prescription in children were developed in the 1950s. These guidelines based on the use of hypotonic solutions have been challenged regularly for they seem to be associated with an increas... | BETAMETHASONE, CALCIUM, DEXTROSE, POTASSIUM, SODIUM CHLORIDE | DrugsGivenReaction | CC BY | 34099019 | 19,499,359 | 2021-06-07 |
What is the weight of the patient? | From hypotonic maintenance fluid to severe hyponatremia: a case report.
BACKGROUND
The principles for maintenance intravenous fluid prescription in children were developed in the 1950s. These guidelines based on the use of hypotonic solutions have been challenged regularly for they seem to be associated with an increas... | 2.8 kg. | Weight | CC BY | 34099019 | 19,499,359 | 2021-06-07 |
What was the administration route of drug 'CALCIUM'? | From hypotonic maintenance fluid to severe hyponatremia: a case report.
BACKGROUND
The principles for maintenance intravenous fluid prescription in children were developed in the 1950s. These guidelines based on the use of hypotonic solutions have been challenged regularly for they seem to be associated with an increas... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34099019 | 19,499,359 | 2021-06-07 |
What was the administration route of drug 'DEXTROSE'? | From hypotonic maintenance fluid to severe hyponatremia: a case report.
BACKGROUND
The principles for maintenance intravenous fluid prescription in children were developed in the 1950s. These guidelines based on the use of hypotonic solutions have been challenged regularly for they seem to be associated with an increas... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34099019 | 19,499,359 | 2021-06-07 |
What was the administration route of drug 'POTASSIUM'? | From hypotonic maintenance fluid to severe hyponatremia: a case report.
BACKGROUND
The principles for maintenance intravenous fluid prescription in children were developed in the 1950s. These guidelines based on the use of hypotonic solutions have been challenged regularly for they seem to be associated with an increas... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34099019 | 19,499,359 | 2021-06-07 |
What was the administration route of drug 'SODIUM CHLORIDE'? | From hypotonic maintenance fluid to severe hyponatremia: a case report.
BACKGROUND
The principles for maintenance intravenous fluid prescription in children were developed in the 1950s. These guidelines based on the use of hypotonic solutions have been challenged regularly for they seem to be associated with an increas... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34099019 | 19,499,359 | 2021-06-07 |
What was the dosage of drug 'BETAMETHASONE'? | From hypotonic maintenance fluid to severe hyponatremia: a case report.
BACKGROUND
The principles for maintenance intravenous fluid prescription in children were developed in the 1950s. These guidelines based on the use of hypotonic solutions have been challenged regularly for they seem to be associated with an increas... | .375 mg (milligrams). | DrugDosage | CC BY | 34099019 | 19,499,359 | 2021-06-07 |
What was the outcome of reaction 'Hyponatraemia'? | From hypotonic maintenance fluid to severe hyponatremia: a case report.
BACKGROUND
The principles for maintenance intravenous fluid prescription in children were developed in the 1950s. These guidelines based on the use of hypotonic solutions have been challenged regularly for they seem to be associated with an increas... | Recovered | ReactionOutcome | CC BY | 34099019 | 19,499,359 | 2021-06-07 |
What was the outcome of reaction 'Hyponatraemic encephalopathy'? | From hypotonic maintenance fluid to severe hyponatremia: a case report.
BACKGROUND
The principles for maintenance intravenous fluid prescription in children were developed in the 1950s. These guidelines based on the use of hypotonic solutions have been challenged regularly for they seem to be associated with an increas... | Recovered | ReactionOutcome | CC BY | 34099019 | 19,499,359 | 2021-06-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Serious complications in COVID-19 ARDS cases: pneumothorax, pneumomediastinum, subcutaneous emphysema and haemothorax.
The novel coronavirus identified as severe acute respiratory syndrome-coronavirus-2 causes acute respiratory distress syndrome (ARDS). Our aim in this study is to assess the incidence of life-threateni... | ASCORBIC ACID, AZITHROMYCIN ANHYDROUS, FAVIPIRAVIR, HYDROXYCHLOROQUINE | DrugsGivenReaction | CC BY | 34099076 | 19,960,644 | 2021-06-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Deafness neurosensory'. | Liposomal amphotericin B-induced reversible ototoxicity in a patient with disseminated histoplasmosis.
Amphotericin B (AmB) is a polyene antifungal agent used widely for systemic fungal infections. Infusion-related side effects, nephrotoxicity, and dyselectrolytemia are well-known adverse effects with the use of this d... | AMPHOTERICIN B | DrugsGivenReaction | CC BY-NC-SA | 34100400 | 20,557,197 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ototoxicity'. | Liposomal amphotericin B-induced reversible ototoxicity in a patient with disseminated histoplasmosis.
Amphotericin B (AmB) is a polyene antifungal agent used widely for systemic fungal infections. Infusion-related side effects, nephrotoxicity, and dyselectrolytemia are well-known adverse effects with the use of this d... | AMPHOTERICIN B | DrugsGivenReaction | CC BY-NC-SA | 34100400 | 20,557,197 | 2021 |
What was the administration route of drug 'AMPHOTERICIN B'? | Liposomal amphotericin B-induced reversible ototoxicity in a patient with disseminated histoplasmosis.
Amphotericin B (AmB) is a polyene antifungal agent used widely for systemic fungal infections. Infusion-related side effects, nephrotoxicity, and dyselectrolytemia are well-known adverse effects with the use of this d... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-SA | 34100400 | 20,557,197 | 2021 |
What was the outcome of reaction 'Deafness neurosensory'? | Liposomal amphotericin B-induced reversible ototoxicity in a patient with disseminated histoplasmosis.
Amphotericin B (AmB) is a polyene antifungal agent used widely for systemic fungal infections. Infusion-related side effects, nephrotoxicity, and dyselectrolytemia are well-known adverse effects with the use of this d... | Recovered | ReactionOutcome | CC BY-NC-SA | 34100400 | 20,557,197 | 2021 |
What was the outcome of reaction 'Ototoxicity'? | Liposomal amphotericin B-induced reversible ototoxicity in a patient with disseminated histoplasmosis.
Amphotericin B (AmB) is a polyene antifungal agent used widely for systemic fungal infections. Infusion-related side effects, nephrotoxicity, and dyselectrolytemia are well-known adverse effects with the use of this d... | Recovered | ReactionOutcome | CC BY-NC-SA | 34100400 | 20,557,197 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Neutropenia, Thrombocytopenia, and Eosinophilia: An Unusual Triad in a Patient on Long-Term Vancomycin Therapy.
BACKGROUND Vancomycin is an antibiotic commonly used for management of severe gram-positive infections. It is infrequently associated with hematologic adverse effects, ranging from isolated thrombocytopenia o... | ACETAMINOPHEN, CEFEPIME HYDROCHLORIDE, CYCLOBENZAPRINE, DAPTOMYCIN, ENOXAPARIN, METRONIDAZOLE, OXYCODONE, PREGABALIN, VANCOMYCIN | DrugsGivenReaction | CC BY-NC-ND | 34101721 | 19,461,740 | 2021-06-08 |
What was the dosage of drug 'ACETAMINOPHEN'? | Neutropenia, Thrombocytopenia, and Eosinophilia: An Unusual Triad in a Patient on Long-Term Vancomycin Therapy.
BACKGROUND Vancomycin is an antibiotic commonly used for management of severe gram-positive infections. It is infrequently associated with hematologic adverse effects, ranging from isolated thrombocytopenia o... | UNKNOWN | DrugDosageText | CC BY-NC-ND | 34101721 | 19,471,520 | 2021-06-08 |
What was the dosage of drug 'CYCLOBENZAPRINE'? | Neutropenia, Thrombocytopenia, and Eosinophilia: An Unusual Triad in a Patient on Long-Term Vancomycin Therapy.
BACKGROUND Vancomycin is an antibiotic commonly used for management of severe gram-positive infections. It is infrequently associated with hematologic adverse effects, ranging from isolated thrombocytopenia o... | UNKNOWN | DrugDosageText | CC BY-NC-ND | 34101721 | 19,471,520 | 2021-06-08 |
What was the dosage of drug 'ENOXAPARIN'? | Neutropenia, Thrombocytopenia, and Eosinophilia: An Unusual Triad in a Patient on Long-Term Vancomycin Therapy.
BACKGROUND Vancomycin is an antibiotic commonly used for management of severe gram-positive infections. It is infrequently associated with hematologic adverse effects, ranging from isolated thrombocytopenia o... | UNKNOWN | DrugDosageText | CC BY-NC-ND | 34101721 | 19,471,520 | 2021-06-08 |
What was the dosage of drug 'OXYCODONE'? | Neutropenia, Thrombocytopenia, and Eosinophilia: An Unusual Triad in a Patient on Long-Term Vancomycin Therapy.
BACKGROUND Vancomycin is an antibiotic commonly used for management of severe gram-positive infections. It is infrequently associated with hematologic adverse effects, ranging from isolated thrombocytopenia o... | UNKNOWN | DrugDosageText | CC BY-NC-ND | 34101721 | 19,471,520 | 2021-06-08 |
What was the dosage of drug 'PREGABALIN'? | Neutropenia, Thrombocytopenia, and Eosinophilia: An Unusual Triad in a Patient on Long-Term Vancomycin Therapy.
BACKGROUND Vancomycin is an antibiotic commonly used for management of severe gram-positive infections. It is infrequently associated with hematologic adverse effects, ranging from isolated thrombocytopenia o... | UNKNOWN | DrugDosageText | CC BY-NC-ND | 34101721 | 19,471,520 | 2021-06-08 |
What was the outcome of reaction 'Leukopenia'? | Neutropenia, Thrombocytopenia, and Eosinophilia: An Unusual Triad in a Patient on Long-Term Vancomycin Therapy.
BACKGROUND Vancomycin is an antibiotic commonly used for management of severe gram-positive infections. It is infrequently associated with hematologic adverse effects, ranging from isolated thrombocytopenia o... | Recovered | ReactionOutcome | CC BY-NC-ND | 34101721 | 19,457,829 | 2021-06-08 |
What was the outcome of reaction 'Neutropenia'? | Neutropenia, Thrombocytopenia, and Eosinophilia: An Unusual Triad in a Patient on Long-Term Vancomycin Therapy.
BACKGROUND Vancomycin is an antibiotic commonly used for management of severe gram-positive infections. It is infrequently associated with hematologic adverse effects, ranging from isolated thrombocytopenia o... | Recovered | ReactionOutcome | CC BY-NC-ND | 34101721 | 19,454,214 | 2021-06-08 |
What was the outcome of reaction 'Thrombocytopenia'? | Neutropenia, Thrombocytopenia, and Eosinophilia: An Unusual Triad in a Patient on Long-Term Vancomycin Therapy.
BACKGROUND Vancomycin is an antibiotic commonly used for management of severe gram-positive infections. It is infrequently associated with hematologic adverse effects, ranging from isolated thrombocytopenia o... | Recovered | ReactionOutcome | CC BY-NC-ND | 34101721 | 19,454,214 | 2021-06-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute kidney injury'. | Immune checkpoint inhibitor-associated acute kidney injury and mortality: An observational study.
Immune checkpoint inhibitors, approved for the treatment of various types of cancer, are known to cause a unique spectrum of side effects, including acute kidney injury (AKI). The aim of this study was to describe the inci... | CARFILZOMIB | DrugsGivenReaction | CC BY | 34101756 | 20,197,417 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Death'. | Immune checkpoint inhibitor-associated acute kidney injury and mortality: An observational study.
Immune checkpoint inhibitors, approved for the treatment of various types of cancer, are known to cause a unique spectrum of side effects, including acute kidney injury (AKI). The aim of this study was to describe the inci... | CARFILZOMIB | DrugsGivenReaction | CC BY | 34101756 | 20,197,417 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Myeloma cast nephropathy'. | Immune checkpoint inhibitor-associated acute kidney injury and mortality: An observational study.
Immune checkpoint inhibitors, approved for the treatment of various types of cancer, are known to cause a unique spectrum of side effects, including acute kidney injury (AKI). The aim of this study was to describe the inci... | CARFILZOMIB | DrugsGivenReaction | CC BY | 34101756 | 20,197,417 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Myositis'. | Immune checkpoint inhibitor-associated acute kidney injury and mortality: An observational study.
Immune checkpoint inhibitors, approved for the treatment of various types of cancer, are known to cause a unique spectrum of side effects, including acute kidney injury (AKI). The aim of this study was to describe the inci... | CARFILZOMIB | DrugsGivenReaction | CC BY | 34101756 | 20,197,417 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Obstructive nephropathy'. | Immune checkpoint inhibitor-associated acute kidney injury and mortality: An observational study.
Immune checkpoint inhibitors, approved for the treatment of various types of cancer, are known to cause a unique spectrum of side effects, including acute kidney injury (AKI). The aim of this study was to describe the inci... | CARFILZOMIB | DrugsGivenReaction | CC BY | 34101756 | 20,197,417 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Renal impairment'. | Immune checkpoint inhibitor-associated acute kidney injury and mortality: An observational study.
Immune checkpoint inhibitors, approved for the treatment of various types of cancer, are known to cause a unique spectrum of side effects, including acute kidney injury (AKI). The aim of this study was to describe the inci... | CARFILZOMIB | DrugsGivenReaction | CC BY | 34101756 | 20,197,417 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Tubulointerstitial nephritis'. | Immune checkpoint inhibitor-associated acute kidney injury and mortality: An observational study.
Immune checkpoint inhibitors, approved for the treatment of various types of cancer, are known to cause a unique spectrum of side effects, including acute kidney injury (AKI). The aim of this study was to describe the inci... | CARFILZOMIB | DrugsGivenReaction | CC BY | 34101756 | 20,197,417 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Urinary tract infection'. | Immune checkpoint inhibitor-associated acute kidney injury and mortality: An observational study.
Immune checkpoint inhibitors, approved for the treatment of various types of cancer, are known to cause a unique spectrum of side effects, including acute kidney injury (AKI). The aim of this study was to describe the inci... | CARFILZOMIB | DrugsGivenReaction | CC BY | 34101756 | 20,197,417 | 2021 |
What was the outcome of reaction 'Acute kidney injury'? | Immune checkpoint inhibitor-associated acute kidney injury and mortality: An observational study.
Immune checkpoint inhibitors, approved for the treatment of various types of cancer, are known to cause a unique spectrum of side effects, including acute kidney injury (AKI). The aim of this study was to describe the inci... | Fatal | ReactionOutcome | CC BY | 34101756 | 20,197,417 | 2021 |
What was the outcome of reaction 'Death'? | Immune checkpoint inhibitor-associated acute kidney injury and mortality: An observational study.
Immune checkpoint inhibitors, approved for the treatment of various types of cancer, are known to cause a unique spectrum of side effects, including acute kidney injury (AKI). The aim of this study was to describe the inci... | Fatal | ReactionOutcome | CC BY | 34101756 | 20,197,417 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Agranulocytosis'. | Lacosamide-induced sinus node dysfunction followed by severe agranulocytosis.
BACKGROUND
Lacosamide (LCM) is the antiepileptic drug approved by the U.S. Food and Drug Administration in 2008 that facilitates slow activation of the voltage-gated sodium channels. Neutropenia and cardiac events including sinus node dysfunc... | LACOSAMIDE, LEVETIRACETAM, PHENYTOIN SODIUM | DrugsGivenReaction | CC BY | 34102997 | 19,549,181 | 2021-06-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Septic shock'. | Lacosamide-induced sinus node dysfunction followed by severe agranulocytosis.
BACKGROUND
Lacosamide (LCM) is the antiepileptic drug approved by the U.S. Food and Drug Administration in 2008 that facilitates slow activation of the voltage-gated sodium channels. Neutropenia and cardiac events including sinus node dysfunc... | LACOSAMIDE, LEVETIRACETAM, PHENYTOIN SODIUM | DrugsGivenReaction | CC BY | 34102997 | 19,549,181 | 2021-06-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Sinus bradycardia'. | Lacosamide-induced sinus node dysfunction followed by severe agranulocytosis.
BACKGROUND
Lacosamide (LCM) is the antiepileptic drug approved by the U.S. Food and Drug Administration in 2008 that facilitates slow activation of the voltage-gated sodium channels. Neutropenia and cardiac events including sinus node dysfunc... | LACOSAMIDE, LEVETIRACETAM, PHENYTOIN SODIUM | DrugsGivenReaction | CC BY | 34102997 | 19,549,181 | 2021-06-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Sinus node dysfunction'. | Lacosamide-induced sinus node dysfunction followed by severe agranulocytosis.
BACKGROUND
Lacosamide (LCM) is the antiepileptic drug approved by the U.S. Food and Drug Administration in 2008 that facilitates slow activation of the voltage-gated sodium channels. Neutropenia and cardiac events including sinus node dysfunc... | LACOSAMIDE, LEVETIRACETAM, PHENYTOIN SODIUM | DrugsGivenReaction | CC BY | 34102997 | 19,549,181 | 2021-06-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Somnolence'. | Lacosamide-induced sinus node dysfunction followed by severe agranulocytosis.
BACKGROUND
Lacosamide (LCM) is the antiepileptic drug approved by the U.S. Food and Drug Administration in 2008 that facilitates slow activation of the voltage-gated sodium channels. Neutropenia and cardiac events including sinus node dysfunc... | LACOSAMIDE, LEVETIRACETAM, PHENYTOIN SODIUM | DrugsGivenReaction | CC BY | 34102997 | 19,549,181 | 2021-06-08 |
What is the weight of the patient? | Lacosamide-induced sinus node dysfunction followed by severe agranulocytosis.
BACKGROUND
Lacosamide (LCM) is the antiepileptic drug approved by the U.S. Food and Drug Administration in 2008 that facilitates slow activation of the voltage-gated sodium channels. Neutropenia and cardiac events including sinus node dysfunc... | 42 kg. | Weight | CC BY | 34102997 | 19,549,181 | 2021-06-08 |
What was the administration route of drug 'LACOSAMIDE'? | Lacosamide-induced sinus node dysfunction followed by severe agranulocytosis.
BACKGROUND
Lacosamide (LCM) is the antiepileptic drug approved by the U.S. Food and Drug Administration in 2008 that facilitates slow activation of the voltage-gated sodium channels. Neutropenia and cardiac events including sinus node dysfunc... | Oral | DrugAdministrationRoute | CC BY | 34102997 | 19,549,181 | 2021-06-08 |
What was the outcome of reaction 'Agranulocytosis'? | Lacosamide-induced sinus node dysfunction followed by severe agranulocytosis.
BACKGROUND
Lacosamide (LCM) is the antiepileptic drug approved by the U.S. Food and Drug Administration in 2008 that facilitates slow activation of the voltage-gated sodium channels. Neutropenia and cardiac events including sinus node dysfunc... | Recovering | ReactionOutcome | CC BY | 34102997 | 19,549,181 | 2021-06-08 |
What was the outcome of reaction 'Septic shock'? | Lacosamide-induced sinus node dysfunction followed by severe agranulocytosis.
BACKGROUND
Lacosamide (LCM) is the antiepileptic drug approved by the U.S. Food and Drug Administration in 2008 that facilitates slow activation of the voltage-gated sodium channels. Neutropenia and cardiac events including sinus node dysfunc... | Fatal | ReactionOutcome | CC BY | 34102997 | 19,549,181 | 2021-06-08 |
What was the outcome of reaction 'Sinus bradycardia'? | Lacosamide-induced sinus node dysfunction followed by severe agranulocytosis.
BACKGROUND
Lacosamide (LCM) is the antiepileptic drug approved by the U.S. Food and Drug Administration in 2008 that facilitates slow activation of the voltage-gated sodium channels. Neutropenia and cardiac events including sinus node dysfunc... | Recovering | ReactionOutcome | CC BY | 34102997 | 19,549,181 | 2021-06-08 |
What was the outcome of reaction 'Sinus node dysfunction'? | Lacosamide-induced sinus node dysfunction followed by severe agranulocytosis.
BACKGROUND
Lacosamide (LCM) is the antiepileptic drug approved by the U.S. Food and Drug Administration in 2008 that facilitates slow activation of the voltage-gated sodium channels. Neutropenia and cardiac events including sinus node dysfunc... | Recovering | ReactionOutcome | CC BY | 34102997 | 19,549,181 | 2021-06-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Anti-PD-1 elicits regression of undifferentiated pleomorphic sarcomas with UV-mutation signatures.
Undifferentiated pleomorphic sarcoma (UPS), an aggressive soft-tissue sarcoma of adults, has been characterized by low tumor mutational burden (TMB) and high copy number alterations. Clinical trials of programmed death-1 ... | DOCETAXEL, GEMCITABINE\GEMCITABINE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 34103354 | 19,850,231 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Near Complete Pathologic Response to PD-1 Inhibitor and Radiotherapy in a Patient with Locally Advanced Pancreatic Ductal Adenocarcinoma.
Pancreatic ductal adenocarcinoma (PDAC) remains deadly despite advances in systemic therapies and surgical techniques. While there is increasing utilization of immune therapies acros... | PEMBROLIZUMAB | DrugsGivenReaction | CC BY-NC | 34103944 | 19,498,758 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Dramatic response of refractory metastatic squamous cell carcinoma of the skin with cetuximab/pembrolizumab.
Cutaneous squamous cell carcinoma (cSCC) accounts for 20% of skin cancers. At an advanced stage the prognosis is poor, making cSCC the second leading cause of death from skin cancer. In cases of metastatic or un... | CARBOPLATIN, CETUXIMAB | DrugsGivenReaction | CC BY-NC | 34104225 | 20,599,713 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Treatment failure'. | Dramatic response of refractory metastatic squamous cell carcinoma of the skin with cetuximab/pembrolizumab.
Cutaneous squamous cell carcinoma (cSCC) accounts for 20% of skin cancers. At an advanced stage the prognosis is poor, making cSCC the second leading cause of death from skin cancer. In cases of metastatic or un... | CARBOPLATIN, CETUXIMAB, PEMBROLIZUMAB | DrugsGivenReaction | CC BY-NC | 34104225 | 20,568,250 | 2021 |
What was the dosage of drug 'CARBOPLATIN'? | Dramatic response of refractory metastatic squamous cell carcinoma of the skin with cetuximab/pembrolizumab.
Cutaneous squamous cell carcinoma (cSCC) accounts for 20% of skin cancers. At an advanced stage the prognosis is poor, making cSCC the second leading cause of death from skin cancer. In cases of metastatic or un... | UNK, CYCLE (RECEIVED AS FIRST-LINE SYSTEMIC THERAPY) | DrugDosageText | CC BY-NC | 34104225 | 20,568,250 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ischaemic stroke'. | Neurological complications in COVID-19 - a diagnostic challenge.
With the exponential growth of COVID-19 cases, the neurological complications reported during or after the infection became more common. There is limited knowledge regarding the pathophysiological mechanisms that are responsible for these complications. R... | ACETAMINOPHEN, ASPIRIN, ATORVASTATIN, CLOPIDOGREL BISULFATE, ENOXAPARIN SODIUM, HYDROXYCHLOROQUINE, LOPINAVIR\RITONAVIR | DrugsGivenReaction | CC BY | 34104245 | 19,654,452 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Neurological complications in COVID-19 - a diagnostic challenge.
With the exponential growth of COVID-19 cases, the neurological complications reported during or after the infection became more common. There is limited knowledge regarding the pathophysiological mechanisms that are responsible for these complications. R... | ACETAMINOPHEN, ASPIRIN, ATORVASTATIN, CLOPIDOGREL BISULFATE, ENOXAPARIN SODIUM, HYDROXYCHLOROQUINE, LOPINAVIR\RITONAVIR | DrugsGivenReaction | CC BY | 34104245 | 19,654,452 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Subarachnoid haemorrhage'. | Neurological complications in COVID-19 - a diagnostic challenge.
With the exponential growth of COVID-19 cases, the neurological complications reported during or after the infection became more common. There is limited knowledge regarding the pathophysiological mechanisms that are responsible for these complications. R... | ACETAMINOPHEN, ASPIRIN, ATORVASTATIN, CLOPIDOGREL BISULFATE, ENOXAPARIN SODIUM, HYDROXYCHLOROQUINE, LOPINAVIR\RITONAVIR | DrugsGivenReaction | CC BY | 34104245 | 19,654,452 | 2021 |
What was the dosage of drug 'ACETAMINOPHEN'? | Neurological complications in COVID-19 - a diagnostic challenge.
With the exponential growth of COVID-19 cases, the neurological complications reported during or after the infection became more common. There is limited knowledge regarding the pathophysiological mechanisms that are responsible for these complications. R... | 2 GRAM | DrugDosageText | CC BY | 34104245 | 19,654,452 | 2021 |
What was the dosage of drug 'ASPIRIN'? | Neurological complications in COVID-19 - a diagnostic challenge.
With the exponential growth of COVID-19 cases, the neurological complications reported during or after the infection became more common. There is limited knowledge regarding the pathophysiological mechanisms that are responsible for these complications. R... | 75 MILLIGRAM, DAILY | DrugDosageText | CC BY | 34104245 | 19,654,452 | 2021 |
What was the dosage of drug 'ATORVASTATIN'? | Neurological complications in COVID-19 - a diagnostic challenge.
With the exponential growth of COVID-19 cases, the neurological complications reported during or after the infection became more common. There is limited knowledge regarding the pathophysiological mechanisms that are responsible for these complications. R... | 40 MILLIGRAM, DAILY | DrugDosageText | CC BY | 34104245 | 19,654,452 | 2021 |
What was the dosage of drug 'CLOPIDOGREL BISULFATE'? | Neurological complications in COVID-19 - a diagnostic challenge.
With the exponential growth of COVID-19 cases, the neurological complications reported during or after the infection became more common. There is limited knowledge regarding the pathophysiological mechanisms that are responsible for these complications. R... | 75 MILLIGRAM, DAILY | DrugDosageText | CC BY | 34104245 | 19,654,452 | 2021 |
What was the dosage of drug 'ENOXAPARIN SODIUM'? | Neurological complications in COVID-19 - a diagnostic challenge.
With the exponential growth of COVID-19 cases, the neurological complications reported during or after the infection became more common. There is limited knowledge regarding the pathophysiological mechanisms that are responsible for these complications. R... | 6000 INTERNATIONAL UNIT, DAILY | DrugDosageText | CC BY | 34104245 | 19,654,452 | 2021 |
What was the dosage of drug 'HYDROXYCHLOROQUINE'? | Neurological complications in COVID-19 - a diagnostic challenge.
With the exponential growth of COVID-19 cases, the neurological complications reported during or after the infection became more common. There is limited knowledge regarding the pathophysiological mechanisms that are responsible for these complications. R... | 800 UNK, DAILY | DrugDosageText | CC BY | 34104245 | 19,654,452 | 2021 |
What was the outcome of reaction 'Ischaemic stroke'? | Neurological complications in COVID-19 - a diagnostic challenge.
With the exponential growth of COVID-19 cases, the neurological complications reported during or after the infection became more common. There is limited knowledge regarding the pathophysiological mechanisms that are responsible for these complications. R... | Recovering | ReactionOutcome | CC BY | 34104245 | 19,654,452 | 2021 |
What was the outcome of reaction 'Subarachnoid haemorrhage'? | Neurological complications in COVID-19 - a diagnostic challenge.
With the exponential growth of COVID-19 cases, the neurological complications reported during or after the infection became more common. There is limited knowledge regarding the pathophysiological mechanisms that are responsible for these complications. R... | Recovering | ReactionOutcome | CC BY | 34104245 | 19,654,452 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Abdominal pain upper'. | Acute esophageal necrosis following kidney transplantation.
We are reporting a case of spontaneous acute esophageal necrosis "black esophagus" of unclear etiology in a kidney transplant recipient. A patient with end-stage renal disease due to IgA nephropathy received a deceased-donor kidney transplant. The surgical pro... | ALEMTUZUMAB, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS | DrugsGivenReaction | CC BY | 34104254 | 19,523,148 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Abdominal pain'. | Acute esophageal necrosis following kidney transplantation.
We are reporting a case of spontaneous acute esophageal necrosis "black esophagus" of unclear etiology in a kidney transplant recipient. A patient with end-stage renal disease due to IgA nephropathy received a deceased-donor kidney transplant. The surgical pro... | ALEMTUZUMAB, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS | DrugsGivenReaction | CC BY | 34104254 | 19,523,148 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Chest pain'. | Acute esophageal necrosis following kidney transplantation.
We are reporting a case of spontaneous acute esophageal necrosis "black esophagus" of unclear etiology in a kidney transplant recipient. A patient with end-stage renal disease due to IgA nephropathy received a deceased-donor kidney transplant. The surgical pro... | ALEMTUZUMAB, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS | DrugsGivenReaction | CC BY | 34104254 | 19,523,148 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dyspepsia'. | Acute esophageal necrosis following kidney transplantation.
We are reporting a case of spontaneous acute esophageal necrosis "black esophagus" of unclear etiology in a kidney transplant recipient. A patient with end-stage renal disease due to IgA nephropathy received a deceased-donor kidney transplant. The surgical pro... | ALEMTUZUMAB, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS | DrugsGivenReaction | CC BY | 34104254 | 19,523,148 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dysphagia'. | Acute esophageal necrosis following kidney transplantation.
We are reporting a case of spontaneous acute esophageal necrosis "black esophagus" of unclear etiology in a kidney transplant recipient. A patient with end-stage renal disease due to IgA nephropathy received a deceased-donor kidney transplant. The surgical pro... | ALEMTUZUMAB, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS | DrugsGivenReaction | CC BY | 34104254 | 19,523,148 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Eructation'. | Acute esophageal necrosis following kidney transplantation.
We are reporting a case of spontaneous acute esophageal necrosis "black esophagus" of unclear etiology in a kidney transplant recipient. A patient with end-stage renal disease due to IgA nephropathy received a deceased-donor kidney transplant. The surgical pro... | ALEMTUZUMAB, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS | DrugsGivenReaction | CC BY | 34104254 | 19,523,148 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hiccups'. | Acute esophageal necrosis following kidney transplantation.
We are reporting a case of spontaneous acute esophageal necrosis "black esophagus" of unclear etiology in a kidney transplant recipient. A patient with end-stage renal disease due to IgA nephropathy received a deceased-donor kidney transplant. The surgical pro... | ALEMTUZUMAB, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS | DrugsGivenReaction | CC BY | 34104254 | 19,523,148 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Immunosuppressant drug level increased'. | Acute esophageal necrosis following kidney transplantation.
We are reporting a case of spontaneous acute esophageal necrosis "black esophagus" of unclear etiology in a kidney transplant recipient. A patient with end-stage renal disease due to IgA nephropathy received a deceased-donor kidney transplant. The surgical pro... | ALEMTUZUMAB, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS | DrugsGivenReaction | CC BY | 34104254 | 19,419,061 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nausea'. | Acute esophageal necrosis following kidney transplantation.
We are reporting a case of spontaneous acute esophageal necrosis "black esophagus" of unclear etiology in a kidney transplant recipient. A patient with end-stage renal disease due to IgA nephropathy received a deceased-donor kidney transplant. The surgical pro... | ALEMTUZUMAB, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS | DrugsGivenReaction | CC BY | 34104254 | 19,523,148 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Odynophagia'. | Acute esophageal necrosis following kidney transplantation.
We are reporting a case of spontaneous acute esophageal necrosis "black esophagus" of unclear etiology in a kidney transplant recipient. A patient with end-stage renal disease due to IgA nephropathy received a deceased-donor kidney transplant. The surgical pro... | ALEMTUZUMAB, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS | DrugsGivenReaction | CC BY | 34104254 | 19,523,148 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Acute esophageal necrosis following kidney transplantation.
We are reporting a case of spontaneous acute esophageal necrosis "black esophagus" of unclear etiology in a kidney transplant recipient. A patient with end-stage renal disease due to IgA nephropathy received a deceased-donor kidney transplant. The surgical pro... | MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS | DrugsGivenReaction | CC BY | 34104254 | 19,434,419 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Regurgitation'. | Acute esophageal necrosis following kidney transplantation.
We are reporting a case of spontaneous acute esophageal necrosis "black esophagus" of unclear etiology in a kidney transplant recipient. A patient with end-stage renal disease due to IgA nephropathy received a deceased-donor kidney transplant. The surgical pro... | ALEMTUZUMAB, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS | DrugsGivenReaction | CC BY | 34104254 | 19,523,148 | 2021 |
What was the administration route of drug 'METHYLPREDNISOLONE'? | Acute esophageal necrosis following kidney transplantation.
We are reporting a case of spontaneous acute esophageal necrosis "black esophagus" of unclear etiology in a kidney transplant recipient. A patient with end-stage renal disease due to IgA nephropathy received a deceased-donor kidney transplant. The surgical pro... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34104254 | 19,595,104 | 2021 |
What was the administration route of drug 'PREDNISONE'? | Acute esophageal necrosis following kidney transplantation.
We are reporting a case of spontaneous acute esophageal necrosis "black esophagus" of unclear etiology in a kidney transplant recipient. A patient with end-stage renal disease due to IgA nephropathy received a deceased-donor kidney transplant. The surgical pro... | Oral | DrugAdministrationRoute | CC BY | 34104254 | 19,595,104 | 2021 |
What was the outcome of reaction 'Abdominal pain upper'? | Acute esophageal necrosis following kidney transplantation.
We are reporting a case of spontaneous acute esophageal necrosis "black esophagus" of unclear etiology in a kidney transplant recipient. A patient with end-stage renal disease due to IgA nephropathy received a deceased-donor kidney transplant. The surgical pro... | Recovered | ReactionOutcome | CC BY | 34104254 | 19,523,148 | 2021 |
What was the outcome of reaction 'Abdominal pain'? | Acute esophageal necrosis following kidney transplantation.
We are reporting a case of spontaneous acute esophageal necrosis "black esophagus" of unclear etiology in a kidney transplant recipient. A patient with end-stage renal disease due to IgA nephropathy received a deceased-donor kidney transplant. The surgical pro... | Recovered | ReactionOutcome | CC BY | 34104254 | 19,523,148 | 2021 |
What was the outcome of reaction 'Chest pain'? | Acute esophageal necrosis following kidney transplantation.
We are reporting a case of spontaneous acute esophageal necrosis "black esophagus" of unclear etiology in a kidney transplant recipient. A patient with end-stage renal disease due to IgA nephropathy received a deceased-donor kidney transplant. The surgical pro... | Recovered | ReactionOutcome | CC BY | 34104254 | 19,523,148 | 2021 |
What was the outcome of reaction 'Dyspepsia'? | Acute esophageal necrosis following kidney transplantation.
We are reporting a case of spontaneous acute esophageal necrosis "black esophagus" of unclear etiology in a kidney transplant recipient. A patient with end-stage renal disease due to IgA nephropathy received a deceased-donor kidney transplant. The surgical pro... | Recovered | ReactionOutcome | CC BY | 34104254 | 19,523,148 | 2021 |
What was the outcome of reaction 'Dysphagia'? | Acute esophageal necrosis following kidney transplantation.
We are reporting a case of spontaneous acute esophageal necrosis "black esophagus" of unclear etiology in a kidney transplant recipient. A patient with end-stage renal disease due to IgA nephropathy received a deceased-donor kidney transplant. The surgical pro... | Recovered | ReactionOutcome | CC BY | 34104254 | 19,523,148 | 2021 |
What was the outcome of reaction 'Eructation'? | Acute esophageal necrosis following kidney transplantation.
We are reporting a case of spontaneous acute esophageal necrosis "black esophagus" of unclear etiology in a kidney transplant recipient. A patient with end-stage renal disease due to IgA nephropathy received a deceased-donor kidney transplant. The surgical pro... | Recovered | ReactionOutcome | CC BY | 34104254 | 19,523,148 | 2021 |
What was the outcome of reaction 'Hiccups'? | Acute esophageal necrosis following kidney transplantation.
We are reporting a case of spontaneous acute esophageal necrosis "black esophagus" of unclear etiology in a kidney transplant recipient. A patient with end-stage renal disease due to IgA nephropathy received a deceased-donor kidney transplant. The surgical pro... | Recovered | ReactionOutcome | CC BY | 34104254 | 19,523,148 | 2021 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.